Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Sales | 30,413 | 25,308 | 28,548 | 23,474 |
| Cost of Goods | 20,210 | 17,180 | 23,628 | 18,957 |
| Gross Profit | 10,203 | 8,128 | 4,920 | 4,517 |
| Operating Expenses | 3,722 | 3,717 | 3,247 | 3,690 |
| Operating Income | 6,691 | 4,591 | 2,301 | 1,784 |
| Interest Expense | 599 | 401 | 370 | 154 |
| Other Income | -400 | 1,076 | 487 | -19 |
| Pre-tax Income | 5,692 | 5,266 | 2,418 | 1,611 |
| Income Tax | 2,522 | 2,146 | 969 | 644 |
| Net Income Continuous | 3,169 | 3,120 | 1,449 | 967 |
| Net Income Discontinuous | 1 | N/A | 31 | 485 |
| Net Income | $3,170 | $3,120 | $1,480 | $1,452 |
| EPS Basic Total Ops | 0.65 | 0.64 | 0.31 | 0.30 |
| EPS Basic Continuous Ops | 0.65 | 0.64 | 0.30 | 0.20 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.01 | 0.10 |
| EPS Diluted Total Ops | 0.65 | 0.64 | 0.31 | 0.30 |
| EPS Diluted Continuous Ops | 0.65 | 0.64 | 0.30 | 0.20 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.01 | 0.10 |
| EBITDA(a) | $6,371 | $6,352 | $2,668 | $2,171 |